ClearPoint Neuro, Inc. (CLPT)
USD 11.31
(-6.8%)
USD 11.31
(-6.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 9.94 Million USD | -12.92% |
| 2022 | 11.42 Million USD | -2.99% |
| 2021 | 11.77 Million USD | -50.54% |
| 2020 | 23.81 Million USD | 913.64% |
| 2019 | 2.34 Million USD | -32.51% |
| 2018 | 3.48 Million USD | 19.28% |
| 2017 | 2.91 Million USD | -35.03% |
| 2016 | 4.49 Million USD | 15.52% |
| 2015 | 3.88 Million USD | -49.44% |
| 2014 | 7.69 Million USD | 88.29% |
| 2013 | 4.08 Million USD | -37.49% |
| 2012 | 6.53 Million USD | 86.55% |
| 2011 | 3.5 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.3 Million USD | 0.0% |
| 2024 Q1 | 3.43 Million USD | -100.0% |
| 2023 Q4 | 9.94 Million USD | -27.01% |
| 2023 Q3 | 13.63 Million USD | -1.06% |
| 2023 FY | 9.94 Million USD | -12.92% |
| 2023 Q2 | 13.77 Million USD | 21.99% |
| 2023 Q1 | 11.29 Million USD | -1.16% |
| 2022 Q3 | 11.41 Million USD | -1.06% |
| 2022 Q4 | 11.42 Million USD | 0.1% |
| 2022 FY | 11.42 Million USD | -2.99% |
| 2022 Q1 | 11.65 Million USD | -1.02% |
| 2022 Q2 | 11.53 Million USD | -1.04% |
| 2021 Q3 | 19.68 Million USD | -0.12% |
| 2021 Q4 | 11.77 Million USD | -40.17% |
| 2021 Q1 | 26.84 Million USD | 12.72% |
| 2021 Q2 | 19.7 Million USD | -26.58% |
| 2021 FY | 11.77 Million USD | -50.54% |
| 2020 Q1 | 17.03 Million USD | 625.15% |
| 2020 Q2 | 17.64 Million USD | 3.55% |
| 2020 Q3 | 17.87 Million USD | 1.33% |
| 2020 Q4 | 23.81 Million USD | 33.21% |
| 2020 FY | 23.81 Million USD | 913.64% |
| 2019 FY | 2.34 Million USD | -32.51% |
| 2019 Q1 | 4.01 Million USD | 15.41% |
| 2019 Q3 | 2.16 Million USD | -1.55% |
| 2019 Q2 | 2.2 Million USD | -45.2% |
| 2019 Q4 | 2.34 Million USD | 8.4% |
| 2018 Q2 | 1.27 Million USD | 10.03% |
| 2018 FY | 3.48 Million USD | 19.28% |
| 2018 Q4 | 3.48 Million USD | 4.61% |
| 2018 Q3 | 3.32 Million USD | 160.72% |
| 2018 Q1 | 1.15 Million USD | -60.25% |
| 2017 Q4 | 2.91 Million USD | -39.13% |
| 2017 Q1 | 4.59 Million USD | 2.24% |
| 2017 Q3 | 4.79 Million USD | 2.14% |
| 2017 Q2 | 4.69 Million USD | 2.19% |
| 2017 FY | 2.91 Million USD | -35.03% |
| 2016 Q2 | 6.05 Million USD | -25.27% |
| 2016 Q4 | 4.49 Million USD | 2.31% |
| 2016 FY | 4.49 Million USD | 15.52% |
| 2016 Q1 | 8.09 Million USD | 108.28% |
| 2016 Q3 | 4.39 Million USD | -27.46% |
| 2015 Q2 | 3.77 Million USD | -51.56% |
| 2015 Q3 | 3.82 Million USD | 1.4% |
| 2015 FY | 3.88 Million USD | -49.44% |
| 2015 Q4 | 3.88 Million USD | 1.64% |
| 2015 Q1 | 7.78 Million USD | 1.27% |
| 2014 FY | 7.69 Million USD | 88.29% |
| 2014 Q1 | 7.45 Million USD | 82.46% |
| 2014 Q2 | 7.52 Million USD | 0.99% |
| 2014 Q3 | 7.6 Million USD | 1.05% |
| 2014 Q4 | 7.69 Million USD | 1.12% |
| 2013 Q3 | 4.03 Million USD | -51.57% |
| 2013 Q2 | 8.33 Million USD | 0.5% |
| 2013 Q1 | 8.29 Million USD | 26.9% |
| 2013 FY | 4.08 Million USD | -37.49% |
| 2013 Q4 | 4.08 Million USD | 1.21% |
| 2012 Q3 | 6.52 Million USD | -0.02% |
| 2012 Q4 | 6.53 Million USD | 0.07% |
| 2012 Q2 | 6.53 Million USD | 226.54% |
| 2012 Q1 | 2 Million USD | -42.9% |
| 2012 FY | 6.53 Million USD | 86.55% |
| 2011 FY | 3.5 Million USD | 0.0% |
| 2011 Q4 | 3.5 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 72.442% |
| BrainsWay Ltd. | 239 Thousand USD | -4062.762% |
| Cerus Corporation | 59.79 Million USD | 83.362% |
| Envoy Medical, Inc. | 404 Thousand USD | -2362.624% |
| electroCore, Inc. | 537 Thousand USD | -1752.7% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -82808.333% |
| IceCure Medical Ltd | 376 Thousand USD | -2546.011% |
| Inogen, Inc. | 18.27 Million USD | 45.545% |
| OrthoPediatrics Corp. | 13.45 Million USD | 26.079% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -4899.497% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -2635.316% |
| MaxCyte, Inc. | 17.96 Million USD | 44.632% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -17896.165% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 89.314% |
| PAVmed Inc | 2.96 Million USD | -236.115% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -60.106% |
| RxSight, Inc. | 1.21 Million USD | -721.552% |
| Sight Sciences, Inc. | 31.7 Million USD | 68.623% |
| SI-BONE, Inc. | 36.06 Million USD | 72.414% |
| TELA Bio, Inc. | 40.51 Million USD | 75.444% |
| Treace Medical Concepts, Inc. | 53 Million USD | 81.231% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -554.109% |
| Acutus Medical, Inc. | 32.65 Million USD | 69.532% |
| Talis Biomedical Corporation | 16.78 Million USD | 40.73% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -145.958% |
| CVRx, Inc. | 30.38 Million USD | 67.254% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -878.337% |
| Bioventus Inc. | 366.99 Million USD | 97.289% |
| Venus Concept Inc. | 70.79 Million USD | 85.946% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -699.759% |
| LivaNova PLC | 568.54 Million USD | 98.25% |
| 908 Devices Inc. | 3.92 Million USD | -153.22% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 98.053% |
| Nemaura Medical Inc. | 3.08 Million USD | -222.219% |
| NeuroPace, Inc. | 56.95 Million USD | 82.532% |
| LENSAR, Inc. | 1.75 Million USD | -468.514% |
| Apyx Medical Corporation | 33.18 Million USD | 70.02% |
| Cutera, Inc. | 418.69 Million USD | 97.624% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 33.867% |
| BioSig Technologies, Inc. | 103 Thousand USD | -9559.223% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 63.02% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.33% |
| Axonics, Inc. | 25.84 Million USD | 61.498% |
| Outset Medical, Inc. | 134.59 Million USD | 92.608% |
| IRIDEX Corporation | 1.75 Million USD | -468.19% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 80.621% |
| IRadimed Corporation | 1.61 Million USD | -516.007% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -5552.841% |
| INVO Bioscience, Inc. | 6.77 Million USD | -46.825% |
| Telesis Bio, Inc. | 5.26 Million USD | -88.821% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -66.614% |
| Varex Imaging Corporation | 464.2 Million USD | 97.857% |
| Quipt Home Medical Corp. | 60.82 Million USD | 83.642% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -1592.007% |
| Pulmonx Corporation | 35.08 Million USD | 71.646% |
| Dynatronics Corporation | 3.25 Million USD | -205.327% |
| Modular Medical, Inc. | 817 Thousand USD | -1117.748% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -6488.742% |
| Semler Scientific, Inc. | 70 Thousand USD | -14112.857% |
| InMode Ltd. | 6.61 Million USD | -50.446% |
| Bruker Corporation | 1.14 Billion USD | 99.131% |
| Cytosorbents Corporation | 2.54 Million USD | -291.253% |
| DexCom, Inc. | 2.57 Billion USD | 99.613% |
| Align Technology, Inc. | 96.96 Million USD | 89.74% |
| Viveve Medical, Inc. | 5.12 Million USD | -94.165% |
| ZimVie Inc. | 508.79 Million USD | 98.045% |
| Movano Inc. | 15.00 USD | -66326566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 45.109% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 97.504% |
| Profound Medical Corp. | 4.97 Million USD | -100.003% |
| Insulet Corporation | 1.36 Billion USD | 99.272% |
| enVVeno Medical Corporation | 1.06 Million USD | -835.056% |
| Surmodics, Inc. | 29.4 Million USD | 66.166% |
| iCAD, Inc. | 273 Thousand USD | -3544.322% |
| Nuwellis, Inc. | 221 Thousand USD | -4401.81% |
| Biotricity, Inc. | 10.85 Million USD | 8.353% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 71.534% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -1431.202% |
| InspireMD, Inc. | 1.03 Million USD | -858.478% |
| PAVmed Inc. | 2.96 Million USD | -236.115% |
| BIOLASE, Inc. | 13.98 Million USD | 28.859% |
| Beyond Air, Inc. | 14.72 Million USD | 32.416% |
| FONAR Corporation | 37.92 Million USD | 73.77% |
| AxoGen, Inc. | 46.6 Million USD | 78.652% |
| Vivani Medical, Inc. | 19.31 Million USD | 48.485% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 77.699% |
| Inari Medical, Inc. | 30.35 Million USD | 67.225% |
| UFP Technologies, Inc. | 28 Million USD | 64.468% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -2192.159% |
| Tenon Medical, Inc. | 428 Thousand USD | -2224.533% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -892.914% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -362.275% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.525% |
| Sintx Technologies, Inc. | 3.68 Million USD | -169.84% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 73.272% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -1592.007% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -1569.295% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 98.885% |
| TransMedics Group, Inc. | 506.2 Million USD | 98.035% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -1539.044% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -10657.42% |
| Hyperfine, Inc. | 64 Thousand USD | -15445.313% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 94.729% |
| Biomerica, Inc. | 459 Thousand USD | -2067.538% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -2113.432% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -5136.674% |
| Silk Road Medical, Inc | 75.62 Million USD | 86.844% |